Connection

Zdzislaw Szulc to Drug Synergism

Back to Details
This is a "connection" page, showing publications Zdzislaw Szulc has written about Drug Synergism.
Zdzislaw Szulc
Connection Strength
0.062
Drug Synergism
  1. Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase. PLoS One. 2017; 12(6):e0177805.
    View in: PubMed
    Score: 0.033
  2. Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells. Mol Cancer Ther. 2006 Jun; 5(6):1520-9.
    View in: PubMed
    Score: 0.015
  3. Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine. J Biol Chem. 2005 May 06; 280(18):17601-7.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.